A deep learning-based early alzheimer’s disease detection using magnetic resonance images

Alzheimer’s Disease (AD) is a degenerative, chronic condition of the brain for which there is now no effective treatment. However, there are medications that can slow its development. In order to stop and control the development of AD, earlier diagnosis of the disease is quintessential. Our proposed method’s primary objective is to establish a comprehensive model for the prior detection of Alzheimer’s disease and the categorization of distinct AD stages. This work employs a deep learning methodology, especially CNN. The proposed approach makes use of well-known models that have already been trained to classify medical images, like the EfficentNetB7 model, by applying the transfer learning principle. In order to achieve greater accuracy, convolutional neural networks (CNNs) are frequently scaled up as new resources become available at a fixed cost throughout the construction phase. A compound coefficient is used by the CNN architecture and scaling approach, which is the foundation of the pre-trained EfficientNetB7 model, to scale the dimensions equally. This proposed EfficientNetB7 model is quicker, easier, and more effective than other pre-trained models like VGG19 and InceptionV3. The proposed model includes simple structures that have memory requirements, provide manageable time, overfitting, and low computational complexity as well as training and inference speeds. The Alzheimer’s disease Neuroimaging Initiative (ADNI) dataset was employed for a comprehensive assessment of the method proposed, utilizing well-known performance metrics including sensitivity, specificity, and accuracy. The findings revealed that the improvised results achieved the accuracy metric when compared to existing methods. The EfficientNetB7 model has been enhanced, and this model achieves a sensitivity of 98.08%, specificity-98%, accuracy-98.2%, and F-score-98.95%, for multi-class AD stage classifications.